Literature DB >> 2189939

Primary prevention trials in cardiovascular disease.

S J Pocock1, S G Thompson.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2189939      PMCID： PMC1060587          DOI： 10.1136/jech.44.1.3

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  9 in total

Review 1.  A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint.

Authors:  G H Rutan; R H McDonald; L H Kuller
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

2.  Are primary cancer prevention trials feasible?

Authors:  M Zelen
Journal:  J Natl Cancer Inst       Date:  1988-11-16       Impact factor: 13.506

Review 3.  The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension.

Authors:  P R Hebert; N H Fiebach; K A Eberlein; J O Taylor; C H Hennekens
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

4.  UK heart disease prevention project: incidence and mortality results.

Authors:  G Rose; H D Tunstall-Pedoe; R F Heller
Journal:  Lancet       Date:  1983-05-14       Impact factor: 79.321

5.  Randomization by group: a formal analysis.

Authors:  J Cornfield
Journal:  Am J Epidemiol       Date:  1978-08       Impact factor: 4.897

6.  Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project).

Authors:  P Puska; J T Salonen; A Nissinen; J Tuomilehto; E Vartiainen; H Korhonen; A Tanskanen; P Rönnqvist; K Koskela; J Huttunen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

7.  Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study.

Authors:  T W Meade; H C Wilkes; Y Stirling; P J Brennan; C Kelleher; W Browne
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

8.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

9.  Incidence of non-melanocytic skin cancer treated in Australia.

Authors:  G G Giles; R Marks; P Foley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02
  9 in total
  5 in total

1.  When to stop a clinical trial.

Authors:  S J Pocock
Journal:  BMJ       Date:  1992-07-25

Review 2.  Aspirin and the elderly. Current status.

Authors:  C Silagy
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

3.  Life-style factors associated with changes in serum lipids in a follow-up study of cardiovascular risk factors.

Authors:  M A Martínez-González; J Fernández-García; F Sánchez-Izquierdo; P Lardelli-Claret; J Jiménez Moléon; R Gálvez-Vargas
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

4.  Changes in coronary risk profiles in employees after three years of multifactorial intervention.

Authors:  M A Martínez-González; A Bueno-Cavanillas; F Sánchez-Izquierdo; I Aguinaga Ontoso; J J Jiménez-Moléon; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

5.  Overcoming barriers to engaging socio-economically disadvantaged populations in CHD primary prevention: a qualitative study.

Authors:  Christopher Harkins; Rebecca Shaw; Michelle Gillies; Heather Sloan; Kate Macintyre; Anne Scoular; Caroline Morrison; Fiona Mackay; Heather Cunningham; Paul Docherty; Paul Macintyre; Iain N Findlay
Journal:  BMC Public Health       Date:  2010-07-02       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.